GSA and DHS Launch E-Verify Enforcement Initiative Targeting Contractors
Client Alert | 1 min read | 11.19.26
On November 19, 2026, the U.S. General Services Administration (GSA) and the U.S. Department of Homeland Security (DHS) announced an enforcement initiative, coordinated with the White House Task Force to Eliminate Fraud, identifying more than 1,500 firms holding over $50 billion in federal contracts as potentially noncompliant with E-Verify requirements. The agencies are notifying contractors and giving them 30 days to provide proof of compliance. E-Verify is an online employment-eligibility verification system administered by DHS in partnership with the Social Security Administration (SSA) that checks employee information against federal records; its use is mandatory for certain federal contractors. GSA and DHS are also urging agency Senior Procurement Executives to strengthen compliance screening and proactively identify potential violations. The announcement identifies potential compliance deficiencies, not adjudicated violations or findings that the affected contractors employed unauthorized workers. Companies that receive such outreach should coordinate with human resources and contracts teams to confirm applicable E-Verify obligations, validate enrollment and verification practices, preserve supporting records, and ensure any agency notice receives a timely, substantiated response.
Contacts
Insights
Client Alert | 3 min read | 11.17.26
CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs
On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.
Client Alert | 9 min read | 11.17.26
Priorities and Prospects for AI Legislation in the New Congress
Client Alert | 8 min read | 11.16.26
OCC’s AI Examiner Framework: How Banks’ AI Use Can Trigger Legal Liability and Supervisory Exposure
Client Alert | 3 min read | 11.13.26
Massachusetts Trade Secret Preliminary Injunctions: Prove the Harm, Tailor the Relief




